I believe the video interview gets an overall thumbs up from my perspective. Firstly, it looks like LC has had a PR makeover. Wearing glasses and the full face shot worked to present her image as a top tier biotech CEO. Dr Glover partners LC incredibly well providing enough details around what we can expect from ongoing trials in 2025. Together they indicate Imugene will have the data required to ensure capital flow. The only thing to do now is wait for data to drop and look forward to some kind of commercial outcome. You don’t speak about the first Australian site for Azer cel with 5 more planned unless you have confidence they will be busy…I like that thought…busy trials = quick outcomes
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)